{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:28:13Z","timestamp":1790368093693,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.chest.2023.12.019","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T17:07:26Z","timestamp":1703005646000},"page":"1435-1443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Impact of Antigen Exposure on Outcomes and Treatment Response in Fibrotic Hypersensitivity Pneumonitis"],"prefix":"10.1016","volume":"165","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0133-8826","authenticated-orcid":false,"given":"Monica L.","family":"Mullin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3063-7187","authenticated-orcid":false,"given":"Gustavo","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3358-7699","authenticated-orcid":false,"given":"Daniel-Costin","family":"Marinescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyson W.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Assayag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolene H.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1205-5511","authenticated-orcid":false,"given":"Kerri A.","family":"Johannson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasreen","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Manganas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Marcoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Morisset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7875-4361","authenticated-orcid":false,"given":"Bohyung","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Farrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Ryerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.chest.2023.12.019_bib1","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1164\/rccm.202005-2032ST","article-title":"Diagnosis of hypersensitivity pneumonitis in adults. An official ATS\/JRS\/ALAT clinical practice guideline","volume":"202","author":"Raghu","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2023.12.019_bib2","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/j.chest.2021.03.066","article-title":"Diagnosis and evaluation of hypersensitivity pneumonitis: CHEST guideline and expert panel report","volume":"160","author":"Fern\u00e1ndez P\u00e9rez","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.chest.2023.12.019_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106444","article-title":"Exposures and associations with clinical phenotypes in hypersensitivity pneumonitis: a scoping review","volume":"184","author":"Barnes","year":"2021","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.chest.2023.12.019_bib4","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1378\/chest.12-2623","article-title":"Radiographic fibrosis score predicts survival in hypersensitivity pneumonitis","volume":"144","author":"Mooney","year":"2013","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2023.12.019_bib5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4046\/trd.2020.0012","article-title":"Current diagnosis and management of hypersensitivity pneumonitis","volume":"83","author":"Leone","year":"2020","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"9","key":"10.1016\/j.chest.2023.12.019_bib6","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1080\/1744666X.2016.1182426","article-title":"Treatment and monitoring of hypersensitivity pneumonitis","volume":"12","author":"Miyazaki","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"issue":"5","key":"10.1016\/j.chest.2023.12.019_bib7","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.12-2685","article-title":"Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis","volume":"144","author":"Fern\u00e1ndez P\u00e9rez","year":"2013","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2023.12.019_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00408-018-0187-6","article-title":"Role of antigen type in survival in chronic hypersensitivity pneumonitis","volume":"197","author":"Adams","year":"2019","journal-title":"Lung"},{"issue":"1","key":"10.1016\/j.chest.2023.12.019_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1164\/ajrccm\/145.1.3","article-title":"Effect of corticosteroid treatment on the recovery of pulmonary function in farmer's lung","volume":"145","author":"Kokkarinen","year":"1992","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"10.1016\/j.chest.2023.12.019_bib10","doi-asserted-by":"crossref","first-page":"00016","DOI":"10.1183\/23120541.00016-2017","article-title":"Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis","volume":"3","author":"Adegunsoye","year":"2017","journal-title":"ERJ Open Res"},{"issue":"3","key":"10.1016\/j.chest.2023.12.019_bib11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.chest.2016.10.029","article-title":"Use of mycophenolate mofetil or azathioprine for the management of chronic hypersensitivity pneumonitis","volume":"151","author":"Morisset","year":"2017","journal-title":"Chest"},{"issue":"18","key":"10.1016\/j.chest.2023.12.019_bib12","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.chest.2023.12.019_bib13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S2213-2600(20)30554-3","article-title":"Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial","volume":"9","author":"Behr","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"9","key":"10.1016\/j.chest.2023.12.019_bib14","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2023.12.019_bib15","doi-asserted-by":"crossref","first-page":"3562923","DOI":"10.1155\/2016\/3562923","article-title":"The Canadian Registry for Pulmonary Fibrosis: design and rationale of a national pulmonary fibrosis registry","volume":"2016","author":"Ryerson","year":"2016","journal-title":"Can Respir J"},{"issue":"1","key":"10.1016\/j.chest.2023.12.019_bib16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12890-019-0986-4","article-title":"Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis","volume":"19","author":"Fisher","year":"2019","journal-title":"BMC Pulmonary Med"},{"issue":"9596","key":"10.1016\/j.chest.2023.12.019_bib17","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"Von Elm","year":"2007","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.chest.2023.12.019_bib18","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1513\/AnnalsATS.202008-942ST","article-title":"Exposure assessment tools for hypersensitivity pneumonitis. an official American Thoracic Society workshop report","volume":"17","author":"Johannson","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.chest.2023.12.019_bib19","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1378\/chest.113.3.619","article-title":"Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego","volume":"113","author":"Eakin","year":"1998","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.chest.2023.12.019_bib20","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.rmed.2012.06.018","article-title":"The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis","volume":"106","author":"Swigris","year":"2012","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.chest.2023.12.019_bib21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00435221","article-title":"Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire","volume":"2","author":"Brazier","year":"1993","journal-title":"Qual Life Res"},{"issue":"5","key":"10.1016\/j.chest.2023.12.019_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-5D: a measure of health status from the EuroQol Group","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann Med"},{"issue":"3","key":"10.1016\/j.chest.2023.12.019_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4081\/monaldi.2012.121","article-title":"EuroQol-5D (EQ-5D): an instrument for measuring quality of life","volume":"78","author":"Balestroni","year":"2015","journal-title":"Monaldi Arch Chest Dis"},{"issue":"1","key":"10.1016\/j.chest.2023.12.019_bib24","first-page":"00474","article-title":"Antigen avoidance and outcome of nonfibrotic and fibrotic hypersensitivity pneumonitis","volume":"8","author":"Nishida","year":"2022","journal-title":"ERJ Open Re"},{"issue":"3","key":"10.1016\/j.chest.2023.12.019_bib25","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1164\/rccm.201809-1646OC","article-title":"Telomere length and use of immunosuppressive medications in idiopathic pulmonary fibrosis","volume":"200","author":"Newton","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.chest.2023.12.019_bib26","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1164\/rccm.201902-0360OC","article-title":"Rare protein-altering telomere-related gene variants in patients with chronic hypersensitivity pneumonitis","volume":"200","author":"Ley","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.chest.2023.12.019_bib27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02872-2020","article-title":"Leukocyte telomere length and mycophenolate therapy in chronic hypersensitivity pneumonitis","volume":"57","author":"Adegunsoye","year":"2021","journal-title":"Eur Respir J"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369223059330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369223059330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T23:33:18Z","timestamp":1717803198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369223059330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0012369223059330"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2023.12.019","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Antigen Exposure on Outcomes and Treatment Response in Fibrotic Hypersensitivity Pneumonitis","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2023.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American College of Chest Physicians. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}